negative regulation nlrp3 inflammasome a20 protects arthritis 
rheumatoid arthritis chronic autoinflammatory disease affects -% worlds population characterized widespread joint inflammation interleukin- important mediator cartilage destruction rheumatic diseases1 understanding upstream mechanisms leading production interleukin- beta rheumatoid arthritis limited absence suitable mouse models disease inflammasomes contribute pathology myeloid-cell-specific deletion rheumatoid arthritis susceptibility gene a20/tnfaip3 mice a20myel-ko mice triggers spontaneous erosive polyarthritis resembles rheumatoid arthritis patients2 rheumatoid arthritis a20myel-ko mice rescued deletion tumour necrosis factor receptor ref show however crucially relies nlrp3 inflammasome interleukin- receptor signalling macrophages lacking increased basal lipopolysaccharide-induced expression levels inflammasome adaptor nlrp3 proil-beta b result -deficiency macrophages significantly enhances nlrp3 inflammasome mediated caspase- activation pyroptosis interleukin- beta secretion soluble crystalline nlrp3 stimuli contrast activation nlrc4 aim2 inflammasomes altered importantly increased nlrp3 inflammasome activation contributes pathology rheumatoid arthritis vivo deletion nlrp3 caspase- interleukin- receptor markedly protects rheumatoid-arthritis-associated inflammation cartilage destruction a20myel-ko mice results reveal a20 novel negative regulator nlrp3 inflammasome activation describe a20myel-ko mice first experimental model study role inflammasomes pathology rheumatoid arthritis 
